To produce competent, professional, and compassionate ophthalmologists through unparalleled clinical, surgical, research and leadership education to deliver high-quality eye care to patient populations and communities.

To be globally recognized as the leading ophthalmology residency training program in the region.

1. Recruit high-achieving, motivated and passionate physician candidates with a proven record of academic accomplishment, leadership, and social service.
2. Train competent ophthalmologists who are well-prepared for independent comprehensive clinical and surgical practice and subspecialty fellowship training.
3. Teach, promote, support and reward professionalism in behavior, performance, attitude and accountability.
4. Create, promote and maintain a growth-mindset culture which prioritizes life-long learning, collaboration, adaptability to change, resilience in the face of adversity, continual improvement and innovation.
5. Foster and encourage the practice of evidence-based medicine and scholarly endeavors while encouraging quality improvement and patient safety.
6. Prepare residents to be educators, researchers, and leaders whether for a career in academic medicine or clinical practice.
7. Broaden the capabilities of graduating residents and maximize the yield of training by utilizing elective rotations.

Program Director

DR. MOHAMMED SAID SALIM AL ABRI

Duration of the Residency Training Program

Duration of the Program:

· 5 years of structured training; total of 65 periods, 13 blocks per year, each block is 4 weeks’ duration. These 5 years will be divided into 4 initial years of actual ophthalmology training to meet the ACGME-I requirements and a final 5th year as a year of electives/sub-specialization year to meet the OMSB requirements of 5 years of ophthalmology training.

· Rotation consists of blocks of periods designed in subspecialty.

· Rotations will be designed at the beginning of each academic year by the Program Director.

· On-call schedule will be put up at the beginning of each block by the corresponding hospital in which the resident is rotating in.

Trainee must fulfill a minimum of 75% of each period (3 weeks)

Core Structure:

The main training of Residents will be conducted in one of the OMSB accredited hospitals Al-Nahdha Hospital (ANH), Sultan Qaboos University Hospital (SQUH) & Armed Forces Hospital (AFH). Courses and some Elective rotations will be conducted in other centers and hospitals accredited by OMSB as it will be explained below in the respective items.

 The 5 years ophthalmic training will be divided as followed:

 1. 4 Years’ Ophthalmology training to meet the ACGME-I requirements:

· In the first (PGY1) year, residents will be rotating in medical/general ophthalmology rotations (ward, ophthalmology emergencies, general ophthalmology and pediatric ophthalmology) with introduction to ophthalmic surgeries (mainly extraocular surgeries)

 · In the second and fourth (PGY2& PGY4) year, residents will be rotating in various ophthalmology subspecialties (retina, pediatric ophthalmology, oculoplastics, neuro-ophthalmology, glaucoma, refractive surgery and anterior segment). These two years will be consolidated to gain ophthalmic surgical skills with more responsibilities to patient's care. There will be two blocks set aside for Basic Science Course in Saudi Arabia in year two and two research blocks, one in year two and one in year four.

 · The third (PGY3) year will be a surgical ophthalmology (intraocular surgery) year; residents will be trained to perform various ophthalmic surgeries with main focus on the updated cataract surgeries. In addition, there will be one block of phaco elective rotation in India.

 2. The Final (PGY5) Year - OMSB requirements year.

· This is a subspecialty in ophthalmology year. Residents will have the option to choose between different ophthalmic subspecialties.

 General rotation outlines of the ophthalmology residency:

 · All year level training is divided into 13 blocks (12 rotations plus 1 annual leave)

· PGY-1: Total of 13 blocks distributed as follows: 1 block in Optics and Refraction, 1 block Ward posting, 3 blocks in Pediatric Ophthalmology, 4 blocks in General Ophthalmology, 3 blocks in Emergency Ophthalmology and 1 block annual leave.

 · PGY-2: Total of 13 blocks distributed as follows: 2 blocks Basic Science Course (KSA), 2 blocks in Oculoplastics, 3 blocks in Anterior Segment, and 1 block of each of the following rotation: Glaucoma, Neuro-Ophthalmology, Vitreo-retina, Ward, and Research as well as 1 block annual leave.

 · PGY-3: Total of 13 blocks distributed as follows; 11 blocks in Surgical Ophthalmology/Intraocular surgeries, one block Phaco Course (India) and 1 block annual leave. Residents will be distributed in three affiliated hospitals (ANH, SQUH and AFH) and will focus on lens and cataract surgeries.

 · PGY-4: Total of 13 blocks distributed as follows: one block in Neuro-Ophthalmology, 1 block in Research, 1 block in Refractive Surgery, 2 blocks in Oculoplastic, 3 blocks in Vitreo-retina, 2 blocks Glaucoma, 2 blocks in Pediatric Ophthalmology, and 1 block annual leave.

 · PGY-5: Total of 13 blocks, 12 blocks will be elective rotations among various Ophthalmology Subspecialties (Pediatric Ophthalmology, Oculoplastic, Refractive Surgeries, Neuro-Ophthalmology, Glaucoma, and Vitreo-retina) and 1 annual leave. There will be four rotations during this year each rotation of 3 blocks. The rotation will be determined by the residents after arrangement with the Program Director.

SPECIALTY ADMISSION CRITERIA

 1. The trainee is selected as per the OMSB rules and regulations.

2. The number of residents accepted each year will be decided by the ophthalmology training program after approval from OMSB.

3. The trainee:

a. Should register with OMSB and abide by all its bylaws.

b. Must pass an interview conducted by the Ophthalmology Education Committee.

c. Should demonstrate interest in Ophthalmology.

d. Must successfully complete his / her Internship which requires submission of records of completion.

e. Should be medically fit as per OMSB requirements. 

f. Should meet the ophthalmology fitness criteria (visual acuity, binocularity, etc.)

g. Must submit a letter of approval from his/ her sponsor confirming permission to join the OMSB specialty training program on full time basis for the entire period of training.

h. Provide three letters of recommendation from three consultants.

Training Center:

1. Sultan Qaboos University Hospital (SQOH)

2. Al Nahda Hospital (ANH)

3. Armed Forces Hospital (AFH)

4. Muscat Eye Laser Center (MELC)

Training Center:

1. Sahai Hospital (India)

General OMSB Evaluation Tools (list of evaluation forms only)

· ITAR In-Training Evaluation Report 

· MINI-CEX evaluation

· Case Based Discussion Evaluation

· Presentation/Journal Clubs/Grand Round Evaluations

· 360-degree Multi-Source Feedback Evaluation

· Research Round Evaluation & Research Block Evaluation  

· Semi-Annual and Annual Evaluations 

· Milestones Evaluations 

· Exams: End-of-Course Assessments, End-of-year Viva Exam, OMSB part I 

· The Final In-Training Assessment Report

Progression Examinations

OMSB Part 1

VIVA Exam

Exit Qualification

OMSB Part 2 (Written and Clinical)

Other International Examinations

Optional Examinations

Arab board Examination

FRCS Ophthalmology Exam

ICO

No.1

Academic Activity

Frequency

1.       

 

 

 

 

 

 

 

 

Wednesday Half-day Teaching Three Courses a year the following topic:

-       Neuro-Ophthalmology Course

-       Glaucoma Course

-       Clinical Optics, Refraction and Refractive Surgery

-       Cornea and External Disease

-       Lens, Cataract and Ophthalmic Surgery

-       Orbit, Eyelids and Lacrimal System

-       Pediatric Ophthalmology and Strabismus

-       Retina and Vitreous

Once a week (Wednesday) 1-4 PM

2.       

Ophthalmic Simulation Training

Once a week

(Every Tuesday 2-4pm)

3.

Ophthalmic Simulation Eyesi Training (Dry and Wet lab) 

November /April

4.

Orientation of New Residents   

August

5.

Journal Club

Every 2 months

Starting (September)

6.

Ophthalmology Symposium

Every 2 months

Starting (October)

7.       

Basic Science Course

September / October

8.       

OMSB Part 2 Exam (R5) Written

September

9.

OSCE for OMSB Part 2 Exam (R5)

November

10.

OMSB Part 1 (R2-R3) 

July

11.

Research Result Round

October

12.

Research Proposal Round

April

13.

OMSB Research Day/Career Day

December

14.

Phaco Elective (R3) India

December -March

15.

6 Monthly Evaluation    

February

16.

Annual Evaluation    

July/August

17.

Retreat Day   

November – March

18.   

VIVA Exam (All Residents) 

May

19.

End of course exam

November -April

Research

Year

Resident

Project Title

 

Supervisor

Key Words

2011

Dr. Amna Al-Hosni

2011

Macular cysts in retinal dystrophy

Dr. Anuradha Ganesh

 

 

Dr. Huda Al-Waili

2011

Retinopathy of Prematurity in Sultan Qaboos University Hospital (SQUH), Oman

Dr. Sana Al-Zuhaibi

 

2012

Dr. Khalifa Al-Ismaily

2013

Comparison of Atropine and Cyclopentolate in refractive accommodative esotropia

Dr. Anuradha Ganesh

 

 

Dr. Majda Al-Yahyai

2015

Pattern of Childhood Blindness and Severe visual impairment: A hospital based study in Oman.

Dr. Kishore H

 

 

Dr. Manal Al-Dahri

2012

Retinopathy of prematurity patients treated with intravitreal Avastin Injection

Dr. Rashid Al-Saidi

 

 

Dr. Mohammed Al-Salmi

2012

Surgical outcome after Trabeculectomy in Pediatric Glaucoma at Alnahda Hospital

Dr. Rahima Al-Mahrooqui

 

 

Dr. Amna Al-Hosni

2013

Incidence of malignant eyelid tumors

Dr. Abdullah Al-Mujaini

 

 

Dr. Rayah Al-Hajri

2012

Relationship between glycosylated hemoglobin, urinary protein and severity of diabetic retinopathy in type 2 DM.

Dr. Ahmed Al-Hinai

 

2013

Dr. Saif Bani Al-Oraba

2016

Indications, visual and topographic outcome of Penetrating Keratoplasty in Sultan Qaboos University Hospital

Dr. Nadiya Al-Kharousi

 

 

Dr. Huda Al-Waili

Optical Coherence Tomographic patterns in Diabetic Macular Edema: Prediction of outcome after Intravitreal Triamcinolone Acetonide ( Triesnces ) injections

Dr. Mohammed Al Abri

 

 

Dr. Mohammed A-Salmi

2014

Mature White Cataract - Visual outcome

Dr. Rikin Shah

 

2014

Dr. Abdulrahman Al-Abri

2014

Intravitreal Anti- Vascular Endothelial Growth Factor (VEGF) Treatment Of Macular Edema Secondary To Vascular Occlusive Diseases: A Retrospective Study

Dr. Mohammed Al Abri

 

 

Dr. Muna Al Ajmi

2015

The Association of Papilledema and Cone Dystrophy A Clinical – Genetic Case Series Study in Omani Patients

Dr. Sana Al-Zuhaibi

 

2015

Dr. Huda Al-Farsi

2015

Incidence of orbital implant exposure following enucleation / evisceration procedures

Dr. Abdullah Al-Mujaini

 

 

Dr. Al-Yaqadhan al-Ghafri

2016

The epidemiology on non-viral microbial keratitis in a tertiary care center in Muscat, Oman

Dr. Abdulatif Al-Raisi

 

 

Dr. Ahlam Al-Hamhami

2017

Phenotype and Genotype Characterization of  Leber Congenital Amaurosis in Omanin families: SQUH Experience

Dr. Sana Al-Zuhaibi

 

 

Dr. Abdulrahman Al-Abri

2017

Effect of accelerated collagen corneal cross linking in arresting the progression of keratoconus amongst young Omani population

Dr. Abdulwakil Alugail

 

 

Dr. Ammar Al-Farsi

2018

Use of intravitreal  Ranibizumab (Lucentis®) in the treatment of cystic macular lesions in Retinal Dystrophy

Dr. Anuradha Ganesh

 

 

Dr. Sheikha Al-Azzani

Correlation of central corneal thickness (CCT) with intraocular pressure (IOP) in Omani children: The importance of CCT in pediatric aphakic and pseudophakic glaucoma

Dr. Sana Al-Zuhaibi

 

 

Dr. Majid Al-Shaaibi

2016

Impact of macular ischemia in the treatment of Diabetic Macular Edema 

Dr. Ahmed Al-Hinai

 

2016

Dr. Haitham Al-Mahrooqui

2016

Epidemiology and Clinical Features of keratoconus in Oman

Dr. Abdulatif Al-Raisi

 

 

Dr. Nisreen Al-Belushi

2018

Ocular effects of intravitreal anti-vascular endothelial growth factor (Ranibizumab) for retinopathy of prematurity

Dr. Nassra Al-Habsi

 

2017

Dr. Haitham Al-Mahrooqui

2018

Retinoscopy as a screening tool for keratoconus

Dr. Abdulatif Al-Raisi

 

 

Dr. Majda Al-Yahyai

2017

Comparative study of symmetrical vs asymmetrical inferior oblique weakening surgeries in the treatment of asymmetrical inferior oblique over action: A Pilot study

Dr. Anuradha Ganesh

 

2018

Dr. Adil Al-Musalami

2019

Silicon oil use in vitreo-retinal surgeries: single center experience in Oman. Ongoing study with results

Dr. Mohammed Al Abri

 

 

 

Program Director:

Dr. Aisha Al Busaidi 

Associate Program Director:

Dr. Mohammed Al Abri 

Dr. Mohammed Al Salmi

Dr. Mohammed Al Yarabi

Members:

Dr. Mohammed Al Abri 

Dr. Mohammed Al Salmi

Dr. Mohammed Al Yarabi

Dr. Al Yaqdhan Al Ghafri

Dr. Haitham Al Mahrouqi 

Medical Program Executive: Shahad Al Abri

Program e-mail: ophthalmology@omsb.org

Office number: (968) 24181611